415 related articles for article (PubMed ID: 31271898)
1. More than a messenger: Alternative splicing as a therapeutic target.
Black AJ; Gamarra JR; Giudice J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194395. PubMed ID: 31271898
[TBL] [Abstract][Full Text] [Related]
2. Intronic RNA: Ad'junk' mediator of post-transcriptional gene regulation.
Neil CR; Fairbrother WG
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194439. PubMed ID: 31682938
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial regulation of alternative splicing.
Shenasa H; Hertel KJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194392. PubMed ID: 31276857
[TBL] [Abstract][Full Text] [Related]
4. Small non-coding RNA within the endogenous spliceosome and alternative splicing regulation.
Sperling R
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194406. PubMed ID: 31323432
[TBL] [Abstract][Full Text] [Related]
5. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.
Mourich DV; Iversen PL
Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718
[TBL] [Abstract][Full Text] [Related]
6. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
Urbanski LM; Leclair N; Anczuków O
Wiley Interdiscip Rev RNA; 2018 Jul; 9(4):e1476. PubMed ID: 29693319
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
8. The regulation properties of RNA secondary structure in alternative splicing.
Bartys N; Kierzek R; Lisowiec-Wachnicka J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194401. PubMed ID: 31323437
[TBL] [Abstract][Full Text] [Related]
9. Modification of pre-mRNA splicing by antisense oligonucleotides.
Kole R
Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
[TBL] [Abstract][Full Text] [Related]
10. Antisense therapeutics: New ways to nudge splicing.
Eperon I
Nat Chem Biol; 2012 May; 8(6):507-8. PubMed ID: 22596201
[No Abstract] [Full Text] [Related]
11. Modification of alternative splicing by antisense therapeutics.
Kole R; Vacek M; Williams T
Oligonucleotides; 2004; 14(1):65-74. PubMed ID: 15104897
[TBL] [Abstract][Full Text] [Related]
12. Context matters: Regulation of splice donor usage.
Ptok J; Müller L; Theiss S; Schaal H
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194391. PubMed ID: 31202784
[TBL] [Abstract][Full Text] [Related]
13. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
Sierakowska H; Sambade MJ; Agrawal S; Kole R
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12840-4. PubMed ID: 8917506
[TBL] [Abstract][Full Text] [Related]
14. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
[TBL] [Abstract][Full Text] [Related]
15. Splice-switching small molecules: A new therapeutic approach to modulate gene expression.
Taladriz-Sender A; Campbell E; Burley GA
Methods; 2019 Sep; 167():134-142. PubMed ID: 31203161
[TBL] [Abstract][Full Text] [Related]
16. Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing.
Rigo F; Hua Y; Chun SJ; Prakash TP; Krainer AR; Bennett CF
Nat Chem Biol; 2012 Apr; 8(6):555-61. PubMed ID: 22504300
[TBL] [Abstract][Full Text] [Related]
17. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.
Karras JG; McKay RA; Dean NM; Monia BP
Mol Pharmacol; 2000 Aug; 58(2):380-7. PubMed ID: 10908306
[TBL] [Abstract][Full Text] [Related]
18. How RNA structure dictates the usage of a critical exon of spinal muscular atrophy gene.
Singh NN; Singh RN
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194403. PubMed ID: 31323435
[TBL] [Abstract][Full Text] [Related]
19. Repeat-associated RNA structure and aberrant splicing.
Hale MA; Johnson NE; Berglund JA
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194405. PubMed ID: 31323433
[TBL] [Abstract][Full Text] [Related]
20. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases.
Mercatante DR; Sazani P; Kole R
Curr Cancer Drug Targets; 2001 Nov; 1(3):211-30. PubMed ID: 12188880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
